DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN and HALLUCINATION

98 reports of this reaction

1.1% of all DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN reports

#17 most reported adverse reaction

Overview

HALLUCINATION is the #17 most commonly reported adverse reaction for DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, manufactured by RB Health (US) LLC. There are 98 FDA adverse event reports linking DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN to HALLUCINATION. This represents approximately 1.1% of all 8,751 adverse event reports for this drug.

Patients taking DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN who experience hallucination should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HALLUCINATION98 of 8,751 reports

HALLUCINATION is a less commonly reported adverse event for DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, but still significant enough to appear in the safety profile.

Other Side Effects of DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN

In addition to hallucination, the following adverse reactions have been reported for DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN:

Other Drugs Associated with HALLUCINATION

The following drugs have also been linked to hallucination in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDEAMANTADINEAMANTADINE HYDROCHLORIDEASPIRIN, CAFFEINECALCAREA PHOSPHORICACARBIDOPACARBIDOPA AND LEVODOPACHEWABLE ASPIRINCHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBRDONEPEZIL HYDROCHLORIDEENTACAPONEERTAPENEM SODIUMISTRADEFYLLINELEVODOPALIDOCAINE HCL, MENTHOLLORLATINIBNIGHTTIME COLD AND FLU RELIEFOSELTAMIVIR PHOSPHATEPIMAVANSERIN TARTRATEPRAMIPEXOLE

Frequently Asked Questions

Does DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN cause HALLUCINATION?

HALLUCINATION has been reported as an adverse event in 98 FDA reports for DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HALLUCINATION with DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN?

HALLUCINATION accounts for approximately 1.1% of all adverse event reports for DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, making it a notable side effect.

What should I do if I experience HALLUCINATION while taking DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN?

If you experience hallucination while taking DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN Full ProfileAll Drugs Causing HALLUCINATIONRB Health (US) LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.